Showing results (281-290 of 328) with videos related to

Sort By:
Pageof 33
American Heart Journal|December 5, 2016
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trialRajendra H Mehta, Sean Van Diepen, James Meza, et al.
JAMA|May 11, 2021
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical TrialFernando J Martinez, Eric Yow, Kevin R Flaherty, et al.
European Journal of Heart Failure|September 16, 2024
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and designLars H Lund, Stefan James, Adam D DeVore, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 31, 2019
Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgerySean van Diepen, Rajendra H Mehta, Jeffrey D Leimberger, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
The Journal of Allergy and Clinical Immunology|June 19, 2017
Obesity's effect on asthma extends to diagnostic criteriaNjira Lugogo, Cynthia L Green, Noah Agada, et al.
European Journal of Heart Failure|October 17, 2022
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrumJaved Butler, Muhammad Shariq Usman, Kevin J Anstrom, et al.
Circulation. Heart Failure|June 3, 2022
Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA TrialJaved Butler, Amanda Stebbins, Vojtěch Melenovský, et al.
American Heart Journal|April 15, 2024
Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)Ana Navas-Acien, Regina M Santella, Bonnie R Joubert, et al.
Archives of Internal Medicine|January 16, 2008
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapyGustavo B F Oliveira, Eric M Crespo, Richard C Becker, et al.
Pageof 33